StoxEmami vs Zydus Wellness: share price & financials comparison
NSE: EMAMILTD vs ZYDUSWELL · Fast Moving Consumer Goods · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Emami vs Zydus Wellness at a glance
Emami (EMAMILTD) has a market capitalisation of ₹16,901 Cr, against ₹14,901 Cr for Zydus Wellness (ZYDUSWELL). Over the past year Zydus Wellness has returned -5.0%, compared with -28.8% for Emami. On valuation, Emami trades at a lower P/E of 22.7 versus 60.6. Emami earns a higher return on equity (25.4% vs 4.2%). Emami comes out ahead on size, valuation, profitability and financial health. Zydus Wellness comes out ahead on growth, momentum and technicals. Across the scored metrics below, Emami leads on 8 and Zydus Wellness on 9. On StoxGud's 10-point checklist, Emami scores 7/10 and Zydus Wellness scores 3/10.
| Metric | Emami | Zydus Wellness |
|---|---|---|
| Size | ||
| Market cap | ₹16,901 Cr | ₹14,901 Cr |
| Revenue (latest FY) | ₹3,780 Cr | ₹3,961 Cr |
| Net profit (latest FY) | ₹775 Cr | ₹197 Cr |
| Valuation | ||
| P/E | 22.7 | 60.6 |
| P/B | 5.78 | 2.52 |
| Dividend yield | 3.10% | 0.26% |
| Profitability | ||
| Return on equity | 25.4% | 4.2% |
| Net profit margin | 17.7% | 4.9% |
| Operating margin | 24.2% | 13.1% |
| Growth | ||
| Revenue growth (YoY) | +36.2% | +73.2% |
| Net profit growth (YoY) | -2.8% | — |
| Revenue CAGR (multi-year) | +5.6% | +16.2% |
| Financial health | ||
| Debt to equity | 0.06 | 0.53 |
| Momentum | ||
| 1-month return | +3.1% | -7.7% |
| 1-year return | -28.8% | -5.0% |
| 3-year CAGR | -9.3% | +14.6% |
| 5-year CAGR | -7.1% | +2.8% |
| 10-year CAGR | -4.1% | +10.6% |
| Distance from 52W high | -29.1% | -22.2% |
| Technicals | ||
| RSI (14) | 59 | 37 |
| Price vs 200-day avg | -7.4% | -4.8% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Emami | Zydus Wellness |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✗ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✗ | ✗ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 7/10 | 3/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Emami or Zydus Wellness?
Emami has a market cap of ₹16,901 Cr and Zydus Wellness has a market cap of ₹14,901 Cr as of 06 Nov 2026.
Which has a lower P/E, Emami or Zydus Wellness?
Emami has the lower P/E: Emami trades at 22.7 and Zydus Wellness at 60.6.
Which gave better returns in the last year, Emami or Zydus Wellness?
Zydus Wellness did better: Emami returned -28.8% and Zydus Wellness returned -5.0% over one year.
Is Emami or Zydus Wellness a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Emami scores 7/10 and Zydus Wellness scores 3/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.